Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company focused on cardiometabolic diseases that completed its business combination with Mountain Crest Acquisition Corp. II, sponsored by Mountain Crest Capital LLC, in October 2021. The SPAC raised capital through its 2020 IPO before merging with Better Therapeutics, bringing the company's software-based, prescription cognitive behavioral therapy platform to public markets. The company filed a 424B3 prospectus supplement with the SEC on March 21, 2024, covering resale activity under an existing shelf registration. Better Therapeutics operates in the digital health and healthcare technology sector. Visit SpacDesk and sign up for a full data subscription to access complete filing histories, deal metrics, and real-time monitoring for BTTX and hundreds of other SPAC transactions.